Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,116 | 714 | 99.8% |
| Education | $22.25 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,135 | 116 | $0 (2023) |
| ABBVIE INC. | $1,111 | 67 | $0 (2024) |
| Novo Nordisk Inc | $992.27 | 59 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $730.66 | 50 | $0 (2023) |
| Lilly USA, LLC | $575.18 | 41 | $0 (2023) |
| GlaxoSmithKline, LLC. | $498.34 | 31 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $470.58 | 51 | $0 (2022) |
| Amgen Inc. | $467.62 | 27 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $401.21 | 28 | $0 (2023) |
| Merck Sharp & Dohme LLC | $395.12 | 32 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.06 | 4 | Novartis Pharmaceuticals Corporation ($39.10) |
| 2023 | $1,409 | 75 | AbbVie Inc. ($233.63) |
| 2022 | $1,344 | 76 | ABBVIE INC. ($319.46) |
| 2021 | $1,035 | 82 | AbbVie Inc. ($325.77) |
| 2020 | $894.00 | 54 | PFIZER INC. ($206.79) |
| 2019 | $1,534 | 106 | W. L. Gore & Associates, Inc. ($274.89) |
| 2018 | $1,950 | 165 | Novo Nordisk Inc ($346.10) |
| 2017 | $1,904 | 158 | Janssen Pharmaceuticals, Inc ($260.73) |
All Payment Transactions
720 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Gastroenterology | ||||||
| 11/09/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Diabetes | ||||||
| 10/31/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 10/30/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Oncology | ||||||
| 10/29/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Diabetes Care | ||||||
| 10/20/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: Obesity | ||||||
| 10/11/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
| 09/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Respiratory | ||||||
| 09/12/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Inflammation | ||||||
| 09/12/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Respiratory | ||||||
| 09/11/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 09/07/2023 | SANOFI PASTEUR INC. | FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological), FLUZONE HIGH-DOSE, FLUZONE QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: Vaccines | ||||||
| 09/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Cardio-renal | ||||||
| 08/29/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/24/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Inflammation | ||||||
| 08/18/2023 | Acarix USA Inc. | CADScor System (Device) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: Cardiology | ||||||
| 08/10/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,214 | 1,630 | $260,051 | $129,310 |
| 2022 | 10 | 1,122 | 1,529 | $223,057 | $112,911 |
| 2021 | 10 | 756 | 948 | $145,052 | $78,261 |
| 2020 | 12 | 692 | 787 | $128,572 | $45,247 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 358 | 598 | $124,384 | $51,495 | 41.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 166 | 166 | $35,192 | $22,212 | 63.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 182 | 226 | $33,222 | $14,053 | 42.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 42 | 170 | $14,620 | $8,295 | 56.7% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 27 | 30 | $13,410 | $6,877 | 51.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $9,000 | $6,741 | 74.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 63 | $5,670 | $4,525 | 79.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 206 | 206 | $6,386 | $3,972 | 62.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 19 | 20 | $6,600 | $3,384 | 51.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 19 | 19 | $5,092 | $3,249 | 63.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 72 | 72 | $2,160 | $2,117 | 98.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,510 | $1,654 | 47.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 23 | 23 | $805.00 | $737.15 | 91.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 338 | 566 | $117,728 | $53,114 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 212 | 268 | $39,396 | $16,669 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 120 | 120 | $25,440 | $16,594 | 65.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 33 | 155 | $12,550 | $7,515 | 59.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 84 | 85 | $7,650 | $5,813 | 76.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 206 | 206 | $6,386 | $4,067 | 63.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $4,288 | $2,835 | 66.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 87 | 87 | $2,610 | $2,560 | 98.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 11 | 11 | $2,959 | $1,906 | 64.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,050 | $1,839 | 45.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 201 | 324 | $64,696 | $31,282 | 48.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 117 | 117 | $23,779 | $16,722 | 70.3% |
About Dr. Christopher Smith, DO
Dr. Christopher Smith, DO is a Internal Medicine healthcare provider based in Pottstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598729055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Smith, DO has received a total of $10,138 in payments from pharmaceutical and medical device companies, with $67.06 received in 2024. These payments were reported across 720 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($10,116).
As a Medicare-enrolled provider, Smith has provided services to 3,784 Medicare beneficiaries, totaling 4,894 services with total Medicare billing of $365,729. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Pottstown, PA
- Active Since 04/13/2006
- Last Updated 05/21/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1598729055
Products in Payments
- VRAYLAR (Drug) $531.48
- CHANTIX (Drug) $448.83
- FARXIGA (Drug) $328.83
- TRULICITY (Drug) $305.22
- AFREZZA (Drug) $304.77
- UBRELVY (Drug) $282.77
- JARDIANCE (Drug) $275.07
- CARDIOFORM Septal Occluder (Device) $274.89
- XARELTO (Drug) $272.90
- Vascepa (Drug) $269.42
- ELIQUIS (Drug) $233.60
- SYMBICORT (Drug) $230.86
- Ozempic (Drug) $220.96
- ENTRESTO (Drug) $205.50
- Prolia (Biological) $194.05
- Victoza (Drug) $191.81
- INVOKANA (Drug) $191.66
- TRELEGY ELLIPTA (Drug) $177.28
- JANUVIA (Drug) $159.27
- Kerendia (Drug) $146.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pottstown
Kennedy Sbat, Do, DO
Internal Medicine — Payments: $14,263
Dr. Peter Blackstone, D.o, D.O
Internal Medicine — Payments: $12,152
Richard Saunders, M.d, M.D
Internal Medicine — Payments: $7,171
Mrs. Manjula Raman, Md, MD
Internal Medicine — Payments: $5,226
Dr. Clayton Chang, M.d, M.D
Internal Medicine — Payments: $2,119
Courtney Waters, Md, MD
Internal Medicine — Payments: $1,739